Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Companion Diagnostics Market Size Changed, over the years?

The size of the companion diagnostics market has seen a swift increase in recent years. The market, which was worth $7.34 billion in 2024, is projected to rise to $8.75 billion in 2025, with a compound annual growth rate (CAGR) of 19.3%. The significant growth in the past years has been driven by factors such as greater acceptance of personalized medicine, expansion in oncology and cancer treatment sectors, a surge in collaborative pharmaceutical research and development, initiatives in precision medicine, and the discovery of biomarkers.

How Much Will the Companion Diagnostics Market Be Worth in 2029?

The market size for companion diagnostics is anticipated to experience considerable expansion in the forthcoming years. At a compound annual growth rate (CAGR) of 21.5%, it is set to reach a valuation of $19.07 billion by 2029. Factors contributing to this projected growth during the prediction period include development of targeted therapy, enhancements in infectious disease diagnostics, an increase in biomarker-related drug development, point-of-care testing, and applications of liquid biopsy. The growth is also boosted by innovations in immunotherapy and immunology, the application of artificial intelligence and machine learning in diagnostics, cutting edge product innovations, the adoption of the industry 4.0 blueprint, and strategic collaborations.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7038&type=smp

Which is the Largest Company in the Companion Diagnostics Market?

Major companies operating in the companion diagnostics market include F Hoffmann-La Roche Ltd., Agilent Technologies Inc., Qiagen NV, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Abnova Corp., Amoy Diagnostics Co. Ltd., ARUP Laboratories, Bayer AG, Biomerieux SA, Danaher Corporation, Guardant Health Inc., Illumina Inc., Myriad Genetics Inc., Siemens Healthcare GmbH, Almac Group, Caris Life Sciences, Cepheid Inc., Diaceutics plc, Epic Sciences Inc., Foundation Medicine Inc., Genomic Health Inc., Grail Inc., Hologic Inc., HTG Molecular Diagnostics Inc., Inivata Ltd., Invivoscribe Inc., MolecularMD Corporation, Natera Inc., NeoGenomics Laboratories Inc., Personal Genome Diagnostics Inc., Precision Therapeutics Inc., Prometheus Laboratories Inc., Sividon Diagnostics GmbH, Sysmex Corporation, Ventana Medical Systems, Vermillion Inc.

What Are the Main Market Drivers in the Companion Diagnostics Industry?

The growth of the companion diagnostics market is predicted to be spurred on by the rising number of targeted therapies. Targeted therapy, which is a type of pharmacological therapy, specifically aims at cancer cells’ unique attributes to prevent the disease’s expansion and proliferation. This type of medication circulates throughout the body, but it is typically more targeted than chemotherapy and often results in fewer side effects. Companion diagnostic testing based on biological markers for targeted cancer therapy is increasingly becoming an integral component of individualized cancer treatment. For example, the Personalised Medicine Coalition, a US health care organization, reported in February 2024 that the FDA had approved 16 new personalized treatments for rare disease patients in 2023, a significant increase from the six approved in 2022. Consequently, the escalating number of targeted therapies is fuelling the expansion of the companion diagnostics market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=7038&type=smp

How Is the Companion Diagnostics Market Segments Structured?

The companion diagnostics market covered in this report is segmented –

1) By Product And Service: Assays, Kits And Reagents, Software And Services

2) By Technology: Polymerase Chain Reaction, Next-Generation Sequencing, In Situ Hybridization, Immunohistochemistry

3) By Indication: Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Melanoma

4) By End-User: Pharmaceutical And Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations

Subsegments:

1) By Assays: Polymerase Chain Reaction (PCR) Assays, Immunohistochemistry (IHC) Assays, Next-Generation Sequencing (NGS) Assays, In Situ Hybridization (ISH) Assays

2) By Kits And Reagents: Diagnostic Kits, Detection Reagents, Control Reagents

3) By Software And Services: Data Analysis Software, Interpretation Software, Custom Development Services, Consulting and Support Services

What Strategic Trends Are Transforming the Companion Diagnostics Market?

In the companion diagnostics marketplace, technological advancements are a prevalent trend. The creation of more efficient pharmaceuticals for companion diagnostics is now possible thanks to the use of artificial intelligence. The extensive data sets continually compiled from varying genetic profiles pave the way for the widespread implementation of AI. For example, Deep Genomics, a start-up based in Toronto, employs artificial intelligence to discover superior treatments for genetic diseases and expedite their transition to clinical trials. The intention here is to use deep learning to delve into the human genome, searching for insights into disease origins, and to formulate and evaluate chemical compounds for potential treatment options. This deep learning in a computer environment allows researchers to analyze billions of chemical compounds in hopes of identifying promising substances that can be made into life-saving medicines for people around the globe.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/companion-diagnostics-global-market-report

Which Global Regions Offer the Highest Growth in the Companion Diagnostics Market?

North America was the largest region in the companion diagnostics market in 2024. The regions covered in the companion diagnostics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7038

This Report Delivers Insight On:

1. How big is the companion diagnostics market, and how is it changing globally?

2. Who are the major companies in the companion diagnostics market, and how are they performing?

3. What are the key opportunities and risks in the companion diagnostics market right now?

4. Which products or customer segments are growing the most in the companion diagnostics market?

5. What factors are helping or slowing down the growth of the companion diagnostics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model